SAN ANTONIO — Daily use of low-dose (5 mg) tamoxifen (multiple brands) for a shorter-than-usual treatment period (3 years) for patients with ductal carcinoma in situ (DCIS) and other forms of ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Use of low-dose tamoxifen conferred a sustained reduction in risk for recurrence among women with ...

Tamoxifen has long been used in breast cancer, both in the adjuvant and preventive setting, but uptake and adherence are notoriously low, mainly because of adverse events. Using a much lower dose to ...

Overview: Tamoxifen is commonly used to treat certain types of breast cancer. It is also used to lower your risk of invasive breast cancer and keep some breast cancers from coming back. It blocks ...

SAN ANTONIO – A low-dose treatment of tamoxifen – 5 mg daily rather than the conventional 20 mg daily – appears to offer women protection against recurrence of early stage breast cancer and also ...

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease Women, 40-74 years of age, participating in the Swedish mammography screening program were invited to ...

Low doses of the investigational medicinal product endoxifen reduce breast density to the same extent as the standard treatment tamoxifen, but without causing such troublesome side effects. This is ...

Lapatinib-induced senescent-like phenotype in HER2-positive breast cancer cells. Background: Genetic polymorphisms leading to reduced CYP2D6 activity and the use of CYP2D6 inhibitors both influence ...

The combination of phosphodiesterase type 5 inhibitors (PDE5is) and the selective estrogen receptor modulator tamoxifen ...

The aim of the National Surgical Adjuvant Breast and Bowel Project STAR P-2 trial was to directly compare the effects of raloxifene with those of tamoxifen on the risk of developing breast cancer. The ...